SavedAdd your journal

Journals / Turkish Journal of Biology / 2015 / Cilt: 39 - Sayı: 3

Development of therapeutic proteins: advances and challenges

MUHAMMAD SAJID HAMID AKASH
KANWAL REHMAN
MUHAMMAD TARIQ
SHUQING CHEN
Pages
343–358
Publication Date
2015-08-13
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We made an attempt to discuss all possible factors that are linked with the basis of therapeutic proteins and possible challenges that are currently being faced by scientists during the development of these therapeutic proteins.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Therapeutic proteins have shown to be effective against a variety of diseases.
📊
Key Findings & Data:The significant attention by researchers has resulted in considerable advances in the production and usage of therapeutic proteins in recent years.
💡
Conclusion & Impact:We made an attempt to discuss all possible factors that are linked with the basis of therapeutic proteins and possible challenges that are currently being faced by scientists during the development of these therapeutic proteins.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Therapeutic proteins · protein classification · production of therapeutic proteins

Abstract

Therapeutic proteins have shown to be effective against a variety of diseases. Pharmaceutical companies are progressively focusing on research using proteins in search of novel effective therapeutics. The significant attention by researchers has resulted in considerable advances in the production and usage of therapeutic proteins in recent years. In the current study we focused on the understanding of therapeutic proteins and their impact on the human health care system. Advancements in the field of biotechnology have increased and facilitated the production of therapeutically significant proteins to combat various fatal diseases. Although protein-based therapeutics have taken center stage in drug discovery and development and enhanced safety for human beings, certain challenges remain, including safety and immunogenicity issues, protein stability, and degradation issues. We made an attempt to discuss all possible factors that are linked with the basis of therapeutic proteins and possible challenges that are currently being faced by scientists during the development of these therapeutic proteins.

Özet

Therapeutic proteins have shown to be effective against a variety of diseases. Pharmaceutical companies are progressively focusing on research using proteins in search of novel effective therapeutics. The significant attention by researchers has resulted in considerable advances in the production and usage of therapeutic proteins in recent years. In the current study we focused on the understanding of therapeutic proteins and their impact on the human health care system. Advancements in the field of biotechnology have increased and facilitated the production of therapeutically significant proteins to combat various fatal diseases. Although protein-based therapeutics have taken center stage in drug discovery and development and enhanced safety for human beings, certain challenges remain, including safety and immunogenicity issues, protein stability, and degradation issues. We made an attempt to discuss all possible factors that are linked with the basis of therapeutic proteins and possible challenges that are currently being faced by scientists during the development of these therapeutic proteins.

🔖

Cite This Article

AKASH, M. S. H., REHMAN, K., TARIQ, M., CHEN, S. (2015). Development of therapeutic proteins: advances and challenges. Turkish Journal of Biology, Cilt: 39 - Sayı: 3, 343–358. https://ajindex.com/articles/181746

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Abdel-Razzak Z, Loyer P, Fautrel A, Gautier JC, Corcos L, Turlin B, Beaune P, Guillouzo A (1993). Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture. Mol Pharmacol 44: 707–715.
  2. Ahmad I, Rubbab T, Deeba F, Naqvi SMS (2014). Optimization of E. coli culture conditions for efficient DNA uptake by electroporation. Turk J Biol 38: 568–573.
  3. Ahmed H, HA EZ, Alswiai G (2013). Purification of antioxidant protein isolated from Peganum harmala and its protective effect against CCl4 toxicity in rats. Turk J Biol 37: 39–48. Akash MSH,Shen Q, Rehman K, Chen S (2012a). Interleukin-1 receptor antagonist: a new therapy for type 2 diabetes mellitus. J Pharm Sci 101: 1647–1658.
  4. Akash MSH, Rehman K, Li N, Gao JQ, Sun H, Chen S (2012b). Sustained delivery of IL-1Ra from pluronic F127-based thermosensitive gel prolongs its therapeutic potentials. Pharm Res 29: 3475–3485.
  5. Akash MSH, Rehman K, Chen S (2013a). Role of inflammatory mechanisms in pathogenesis of type 2 diabetes mellitus. J Cell Biochem 114: 525–531.
  6. Akash MSH, Rehman K, Sun H, Chen S (2013b). Interleukin-1 receptor antagonist improves normoglycemia and insulin sensitivity in diabetic Goto-Kakizaki-rats. Eur J Pharmacol 701: 87–95.
  7. Akash MSH, Rehman K, Sun H, Chen S (2013c). Sustained delivery of IL-1Ra from PF127-gel reduces hyperglycemia in diabetic GK-rats. PLoS One 8:e55925. Akash MSH, Rehman K, Chen S (2013d). IL-1Ra and its delivery strategies: inserting the association in perspective. Pharm Res 30: 2951–2966.
  8. Akash MSH, Rehman K, Chen S (2014a). Effects of coffee on type 2 diabetes mellitus. Nutrition 30: 755–763.
  9. Akash MSH, Rehman K, Chen S (2014b). Pluronic F127-based thermosensitive gels for delivery of therapeutic proteins and peptides. Polym Rev 54: 573–597.
  10. Akash MSH, Rehman K, Chen S (2014c). Spice plant Allium cepa: dietary supplement for treatment of type 2 diabetes mellitus. Nutrition 30: 1128–1137.
  11. Akash MSH, Rehman K, Sun H, Chen S (2014d). Assessment of release kinetics, stability and polymer interaction of poloxamer 407-based thermosensitive gel of interleukin-1 receptor antagonist. Pharm Dev Technol 19: 278–284.
  12. Akash MSH, Rehman K, Chen S (2015a). Natural and synthetic polymers as drug carriers for delivery of therapeutic proteins. Polym Rev: DOI:10.1080/15583724.2014.995806. Akash MSH, Rehman K, Chen S (2015b). Polymeric-based particulate systems for delivery of therapeutic proteins. Pharm Dev Technol: DOI: 10.3109/10837450.2014.99